On July 17, 2025, Acurx Pharmaceuticals held its Annual Meeting where shareholders approved six proposals, including a reverse stock split with a ratio between 1:10 and 1:30 and an increase in the 2021 Equity Incentive Plan shares from 177,448 to 2,677,448. Approximately 74.38% of their outstanding shares voted on these measures.